According to relevant studies, VILIP-1 is found in significant concentrations in the serum of ACI patients, and the level of serum VILIP-1 can be used to evaluate the incidence of cerebral infarction and is closely associated with the progression of brain injury [24]. This evidence concerns the gene VSNL1 and brain infarction.